Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-01-05 @ 6:15 PM
Study NCT ID:
NCT01678404
Status:
UNKNOWN
Last Update Posted:
2012-09-05
First Post:
2012-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma
Sponsor:
Korea Cancer Center Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-09
Completion Date Type:
ESTIMATED
First Submit Date:
2012-09-04
First Submit QC Date:
None
Study First Post Date:
2012-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-04
Last Update Post Date:
2012-09-05
Last Update Post Date Type:
ESTIMATED